Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2008, Vol. 13 ›› Issue (6): 675-678.

Previous Articles     Next Articles

Group-biased proof study-logistic regression analysis on Meta analytic data of amlodipine

ZHANG Dai-rong1, HUA Lin2, FU Ying3   

  1. 1Editor Office of Herald Medicine, Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China;
    2Department of Mathematics, Faculty of Biomedical Engineering, Capital Medical University, Beijing 100069, China;
    3Editor Office of Chinese Journal of Pharmacoepidemiology, Wuhan 430030, Hubei, China
  • Received:2008-04-24 Revised:2008-06-02 Published:2020-10-14

Abstract: AIM: To investigate the influence of dosage, therapeutic course, case, group (trial group and contrast group) and publication year on the effectiveness of randomized contrast trials.METHODS: Meta analysis literatures were retrieved from the fulltest data base of CNKI journals in the “Digital Library of Chinese Hospital”.Multiple elements analysis were carried out by binomial logistic regression.RESULTS: One standard-matched literature was got, including 26 clinical contrast trials for the treatment of hypertension by amlodipine, in which 23 cases were randomly divided and 9 cases were treated with amlodipine as the contrast.The course of treatment and groups were both factors for the effectiveness;The therapeutic advantage of trial groups was 2.445-3.690 times as that of contrast.CONCLUSION: In the random contrast test, the tested groups were possibly exaggerated, while the contrast groups depreciated.In the study on Meta analysis and evidence-based medicine, the attention should be paid for the group-bias influence.

Key words: group-bias, amlodipine, hypertension, random contrast clinical trial, Meta analysis, evidence-based medicine, proof study

CLC Number: